WO2021194207A1 - Élément de canal en graphène comprenant une nanovésicule contenant le trpa1, et biocapteur - Google Patents

Élément de canal en graphène comprenant une nanovésicule contenant le trpa1, et biocapteur Download PDF

Info

Publication number
WO2021194207A1
WO2021194207A1 PCT/KR2021/003555 KR2021003555W WO2021194207A1 WO 2021194207 A1 WO2021194207 A1 WO 2021194207A1 KR 2021003555 W KR2021003555 W KR 2021003555W WO 2021194207 A1 WO2021194207 A1 WO 2021194207A1
Authority
WO
WIPO (PCT)
Prior art keywords
graphene
trpa1
channel member
biocide
biosensor
Prior art date
Application number
PCT/KR2021/003555
Other languages
English (en)
Korean (ko)
Inventor
권오석
송현석
김우근
곽지성
김경호
김다혜
김진영
박선주
박유신
박철순
서성은
유용상
윤석주
이상우
이지연
Original Assignee
한국생명공학연구원
한국과학기술연구원
한국화학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국생명공학연구원, 한국과학기술연구원, 한국화학연구원 filed Critical 한국생명공학연구원
Publication of WO2021194207A1 publication Critical patent/WO2021194207A1/fr

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/403—Cells and electrode assemblies
    • G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/403—Cells and electrode assemblies
    • G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
    • G01N27/4145—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS specially adapted for biomolecules, e.g. gate electrode with immobilised receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/403—Cells and electrode assemblies
    • G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
    • G01N27/4146—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS involving nanosized elements, e.g. nanotubes, nanowires
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G01N2430/10—Insecticides

Definitions

  • the present invention relates to a graphene channel member that can be used for detecting a biocide, and a graphene transistor and a biosensor including the same.
  • a transistor is a device capable of amplifying an electrical signal, and based on this, is widely applied in the sensor industry for the purpose of detecting a trace amount of a target material.
  • Graphene is one of the carbon allotropes made of carbon atoms, and while having electrically semi-metallic properties, since the charge acts as a zero effective mass particle therein, it has very high electrical conductivity (intrinsic electron mobility of 20,000 cm 2 /Vs). ) is known to have In particular, since it was reported that there is a field effect characteristic when graphene composed of two-dimensional carbon atoms having a hexagonal structure by mechanical exfoliation of graphite is used in a transistor, graphene is similar to conventional silicon. It is in the spotlight as a material that can replace semiconductor materials.
  • a biocide is a product used to kill or incapacitate living things such as pests, bacteria, and mice that can harm humans, livestock, crops, etc. Since it is composed of ingredients showing effects, it is known that when such biocides are introduced into the human body, they can adversely affect human health. In particular, the dangers and awareness of biocides are increasing day by day due to fatal accidents caused by biocides contained in humidifier disinfectants that have occurred in Korea. The need to develop a technology that can detect it is further emphasized. In addition, waste generated in the process of manufacturing products containing biocides or soil and water pollution by biocides may occur in the process of disposing of the products, so biocides may threaten not only people but also the ecosystem. is a substance in Accordingly, development and research of an efficient biocide sensor is urgent, but the development of a sensor capable of detecting it through a quick and simple method while having high selectivity and sensitivity to the biocide is still insufficient.
  • TRPA1 Transient receptor potential cation channel, subfamily A, member 1
  • Somatosensory receptors known to function in response.
  • As a ligand capable of detecting the binding of TRPA1 various substances such as phenolic compounds of olive oil, thymol, and menthol are known, but biocides such as those described above, for example, PHMG (polyhexamethyleneguanidine), etc. It has not been reported or disclosed that it can be used as a sensor capable of detecting it with high sensitivity by selectively binding to biological agents.
  • TRPA1 can bind with biocides including PHMG with high selectivity and sensitivity, and implements an environment similar to in vivo cells in the sensor for detecting it.
  • the present invention was completed by developing a novel biosensor capable of rapidly and sensitively detecting a biocide.
  • An object of the present invention is to provide a sensor capable of detecting a biocide such as polyhexamethyleneguanidine (PHMG) with high sensitivity, and a graphene channel member capable of selectively reacting with a biocide so that it can be used in the sensor, and the same
  • a biocide such as polyhexamethyleneguanidine (PHMG)
  • PHMG polyhexamethyleneguanidine
  • a graphene channel member capable of selectively reacting with a biocide so that it can be used in the sensor
  • one aspect of the present invention is a graphene channel member including a graphene film and a nanovesicle immobilized on the graphene film, wherein the nanovesicle is a TRPA1 (Transient receptor potential cation channel, It provides a graphene channel member that includes subfamily A, member 1).
  • TRPA1 Transient receptor potential cation channel
  • another aspect of the present invention is the graphene film; And a pair of electrodes; it provides a graphene transistor comprising a.
  • another aspect of the present invention is to provide a biosensor including the graphene transistor, and processing a sample in the biosensor; and measuring an electrical signal of the biosensor.
  • the graphene channel member of the present invention and the graphene transistor and biosensor including the same have selective and specific detection ability for various types of biocides such as PHMG, OIT, CMIT, and MIT by using TRPA1, It can detect even a very small amount of a biocide with a concentration of about 10 ⁇ g/L, which has the effect of being used as a highly sensitive biocide sensor.
  • Figure 2 shows the results of confirming the presence or absence of TRPA1 through western blotting by expressing the gene encoding TRPA1 in HEK-293 cells after transformation.
  • the leftmost part means the result of the marker
  • the middle part means the result of the control group, and it can be seen that a band is formed in the 151 kDa region, which means that TRPA1 is expressed and exists.
  • FIG. 4 is a photograph of a graphene transistor surface-modified with a poly-di-lysine linker.
  • FIG. 5 is a schematic diagram illustrating a graphene channel member in which nanovesicles including TRPA1 are immobilized on a graphene film and a graphene transistor including the same.
  • Nanovesicle/PDL/Gr indicates a transistor in which nanovesicles containing TRPA1 are immobilized on a graphene film through PDL (poly-di-lysine), and PDL/Gr indicates only the PDL linker layer without immobilizing the nanovesicles.
  • a transistor formed on a graphene film, pristine graphene means a transistor made of a graphene film in which the PDL linker layer is not formed.
  • Vds is a source/drain voltage
  • Vg is a gate voltage.
  • FIG. 7 is a graphene transistor (Nanovesicle with receptor) of the present invention and a graphene transistor (Nanovesicle w/p receptor) immobilized with a nanovesicle not containing TRPA1 by injecting PHMG by concentration to measure the value of change in current This is the graph shown.
  • FIG. 8 is a graph showing the measurement of the change amount of current by sequentially inputting OIT, CMIT, and PHMG at the same concentration to the graphene transistor of the present invention.
  • FIG. 9 is a graph showing the amount of change in current by inputting BNP, OIT, MIT, CA, CBDZ, and SPO to the graphene transistor of the present invention for each concentration.
  • FIG. 10 is a graph showing the amount of change in current by sequentially introducing a biocide of a combination of CMIT + OIT, CMIT + PHMG, OIT + PHMG, and CMIT + OIT + PHMG to the graphene transistor of the present invention.
  • 11 is a graphene transistor of the present invention MIT + OIT, MIT + IPBC, MIT + CA, MIT + DDAC, DDAC + IPBC and DDAC + CA combinations of biocides by concentration, respectively, by measuring the amount of change in the current. It is a graph expressed as a sensitivity (sensitivity) numerical value.
  • FIG. 12 is a graph showing the amount of change in current as a sensitivity value by injecting samples of six commercially available household chemical products into the transistor of the present invention. The time of injection of each sample was indicated by an arrow.
  • One aspect of the present invention provides a graphene channel member.
  • the graphene channel member of the present invention includes a graphene film and a nanovesicle immobilized on the graphene film, and the nanovesicle includes a transient receptor potential channel, subfamily A, member 1 (TRPA1).
  • TRPA1 transient receptor potential channel, subfamily A, member 1
  • the nanovesicle of the present invention refers to a nanometer-sized vesicle having a shape surrounded by a membrane composed of a phospholipid bilayer, and may be used interchangeably with 'nanovesicles'.
  • Nanovesicles may have the same size and structure as exosomes, which are membrane-structured vesicles secreted from various types of cells, and are released to the outside of the cell and bind to other cells and tissues, and then protein in the vesicle Unlike exosomes, which serve to deliver substances such as , RNA, etc., nanovesicles are artificially obtained from cells.
  • the nanovesicle has the form of a vesicle surrounded by a membrane composed of a lipid bilayer, and the lipid bilayer membrane may be one or more.
  • the nanovesicle includes a transient receptor potential cation channel (TRPA1, subfamily A, member 1).
  • TRPA1 may be located on the membrane surface of the nanovesicle, and other proteins, glycoproteins, cholesterol, etc. may be bound to the membrane surface in addition to TRPA1.
  • nanovesicles have a cell-like structure, they can provide an environment similar to the actual intracellular environment and cell membrane. Therefore, as TRPA1, which originally exists on the surface of the cell membrane in vivo, is included in the nanovesicle, there is an advantage that TRPA1 can function identically or similarly to that of TRPA1 in vivo.
  • TRPA1 transient receptor potential cation channel
  • the TRPA1 is a kind of ion channel protein also called 'transient receptor potential ankyrin 1'. It is located on the surface of biological membranes of animal cells including humans, detects physical and chemical stress, and is a receptor related to somatosensory sensations such as pain, cold, itch. .
  • TRPA1 contained in the nanovesicles of the present invention can react selectively to biocides.
  • a biocide refers to an agent capable of killing or incapacitating living organisms such as bacteria and insects, and may include preservatives, fungicides, insecticides, rodenticides, preservatives, and the like. In particular, it may be used for the purpose of exterminating pathogens, pests, mice, etc. that damage people, crops, and livestock, but it may be toxic to people, animals, plants, etc. It can cause disease, disability, and even death.
  • the biocide is PHMG (polyhexamethyleneguanidine), BNP (2-bromo-2-nitropropane-1,3-diol), OIT (2-Octyl-3 (2H)-isothiazolone), CMIT (Chloromethylisothiazolinone), MIT (Methylisothiazolinone), CA (Citric acid), CBDZ (Carbendazim), SPO (Sodium 2-pyridinethiol 1-oxide), IPBC (iodopropynyl butylcarbamate) and DDAC (didecyldimethylammonium chloride) may be at least one selected from the group consisting of, and The same biocide may be contained in household chemicals or processed foods.
  • the TRPA1 may have the highest selectivity for PHMG among the biocides listed above. As the TRPA1 selectively binds to the biocide, the structure is changed and channels are opened so that ions existing outside the nanovesicles, such as calcium ions, can move into the nanovesicles. Accordingly, a change in the potential inside and outside the nanovesicle membrane may occur, and an electrical change may occur according to the potential difference before/after TRPA1 binds to the biocide. Therefore, by measuring a change in an electrical signal according to a change in the structure of TRPA1, the TRPA1 can be used for the purpose of confirming the presence of a biocide.
  • the TRPA1 may be a protein comprising the amino acid sequence of SEQ ID NO: 1, and the TRPA1 binds selectively to the biocide and does not affect the detectable activity, deletion or insertion of amino acid residues , may be variants or fragments of amino acids having different sequences by substitution or a combination thereof.
  • Amino acid exchange at the peptide level that selectively binds to the biocide and does not entirely alter its detectable activity is known in the art, and includes, for example, phosphorylation, sulfation, acrylation ( acrylation), glycosylation, methylation, farnesylation, and the like.
  • the present invention includes a protein comprising an amino acid sequence substantially identical to the protein comprising the amino acid sequence of SEQ ID NO: 1, and a variant thereof or an active fragment thereof.
  • the substantially identical protein means an amino acid sequence having 75% or more, for example, 80% or more, 90% or more, 95% or more sequence homology to the amino acid sequence of SEQ ID NO: 1, respectively.
  • the protein may further include a targeting sequence, a tag, a labeled residue, an amino acid sequence prepared for a specific purpose to increase half-life or protein stability.
  • the TRPA1 of the present invention can be obtained by various methods well known in the art. As an example, it may be prepared using polynucleotide recombination and protein expression systems, or synthesized in vitro through chemical synthesis such as peptide synthesis, and cell-free protein synthesis.
  • the N-terminal or A protecting group may be attached to the C-terminus.
  • the protecting group may be an acetyl group, a fluorenyl methoxycarbonyl group, a formyl group, a palmitoyl group, a myristyl group, a stearyl group, or polyethylene glycol (PEG).
  • PEG polyethylene glycol
  • the 'stability' refers to storage stability (eg, room temperature storage stability) as well as in vivo stability that protects the protein of the present invention from attack by a protein cleaving enzyme in vivo.
  • the nanovesicles containing TRPA1 may be prepared by producing and separating animal cells. Specifically, the animal cells are treated with a substance that expresses TRPA1 from animal cells transformed with the gene encoding the TRPA1 protein and reduces the stability of the cell membrane, such as cytochalasin B, and then centrifuged. Nanovesicles can be obtained through Transforming the gene encoding the TRPA1 protein may use any technique and method known in the art that can be used to transform a specific gene in an animal cell, for example, the TRPA1 protein into an expression vector. By cloning the coding gene, it may be transformed into animal cells through treatment with a lipofectamine solution.
  • the diameter of the nanovesicles including TRPA1 may be 100 nm to 200 nm, specifically, 120 nm to 200 nm, 140 nm to 180 nm, 120 nm to 180 nm, or 140 nm to 160 nm. .
  • the diameter of the nanovesicle is smaller than the above range, the amount of TRPA1 that can be included in the nanovesicle may be reduced than the target value, and if the diameter is larger than the above, in the process of immobilizing the nanovesicle to the graphene film can be an obstacle
  • the nanovesicles including the TRPA1 may be immobilized on the graphene film by chemical bonding.
  • the immobilization refers to fixing the nanovesicles so that they do not move at one position of the graphene film, and the structural change of TRPA1 caused by the binding of TRPA1 contained in the nanovesicles with a biocide and the resulting electrical signal. As long as the change is fixed so that it can be transmitted to the graphene film, it can be fixed through any method.
  • the chemical bond is from the group consisting of poly-D-lysine (or PDL), poly-L-lysine and poly-L-ornithine. It may be immobilized by using any one selected as a linker, but it is not limited thereto, and if there is a property that an electron carrier (electron or hole) can move through it and can bind to the graphene film and the nanovesicle, respectively, any It can be used in any form.
  • the poly-di-lysine is a polymer in which a plurality of D-lysine is linked, and forms ionic bonds on the surfaces of graphene films and nanovesicles, respectively, by using the properties of cations represented by lysine. can do.
  • the surface of the graphene film is modified by coating the graphene film with poly-di-lysine, and the nanovesicles of the present invention can be immobilized on the graphene film by binding the nanovesicles to the poly-di-lysine. have.
  • the graphene film may be a single layer or a bi-layer.
  • the graphene film may be patterned, specifically, micro-patterned.
  • the graphene film may be variously patterned in a polygonal shape such as a circle, a triangle, a square, a pentagon, or a hexagon (honeycomb).
  • the nanovesicles including the TRPA1 may be immobilized on the surface of the patterned graphene film.
  • the nanovesicles may be immobilized on the graphene film using poly-di-lysine as a linker.
  • the graphene channel member of the present invention includes a graphene film.
  • a high current flows even in the OFF state where no voltage is applied to the gate, so the on/off ratio of the operating current is very low. It has the advantage of being able to manufacture high-performance transistors.
  • the thickness of the graphene film may be 0.1 to 1 nm, specifically 0.2 to 0.8 nm, 0.3 to 0.8 nm, or 0.5 to 0.7 nm.
  • the thickness of the graphene film refers to the thickness of a single layer of graphene, and when the thickness of the graphene film is within the above range, it exhibits high conductivity and high charge mobility. Available.
  • Another aspect of the present invention provides a graphene transistor.
  • the graphene transistor may include a substrate; The graphene channel member of the present invention; and a pair of electrodes.
  • the substrate serves as a support on which the components of the graphene transistor of the present invention are supported, and an insulating inorganic substrate such as a Si substrate, a glass substrate, a GaN substrate, a silica (SiO 2 ) substrate, and a metal such as Ni, Cu, W A substrate or a plastic substrate may be used, and when an insulating substrate is used, a silica (SiO 2 ) substrate or a silicon wafer is preferable from the viewpoint of excellent affinity with the graphene channel member.
  • an insulating inorganic substrate such as a Si substrate, a glass substrate, a GaN substrate, a silica (SiO 2 ) substrate, and a metal such as Ni, Cu, W
  • a substrate or a plastic substrate may be used, and when an insulating substrate is used, a silica (SiO 2 ) substrate or a silicon wafer is preferable from the viewpoint of excellent affinity with the graphene channel member.
  • the substrate may be selected from various materials capable of depositing graphene, for example, may be made of a material such as silicon-germanium and silicon carbide (SiC), and an epitaxial layer, silicon-on.
  • SiC silicon-germanium and silicon carbide
  • the substrate may be selected from various materials capable of depositing graphene, for example, may be made of a material such as silicon-germanium and silicon carbide (SiC), and an epitaxial layer, silicon-on.
  • SiC silicon-germanium and silicon carbide
  • the graphene channel member may be formed on the substrate.
  • the graphene film may be formed by growing graphene on the substrate by a chemical vapor deposition method using a hydrocarbon gas as a carbon source.
  • the graphene film may be formed using, for example, chemical vapor deposition, and by using this, single to several layers of graphene having excellent crystallinity can be obtained over a large area.
  • the chemical vapor deposition method is a method of growing graphene by adsorbing, decomposing, or reacting a carbon precursor in the form of a gas or vapor having a high kinetic energy on the substrate surface to separate it into carbon atoms, and making the carbon atoms bond with each other. .
  • the chemical vapor deposition method may be at least one selected from the group consisting of Plasma Enhanced Chemical Vapor Deposition (PECVD), Atmospheric Pressure Chemical Vapor Deposition (APCVD), and Low Pressure Chemical Vapor Deposition (LPCVD), and minimize defects in a large area
  • PECVD Plasma Enhanced Chemical Vapor Deposition
  • APCVD Atmospheric Pressure Chemical Vapor Deposition
  • LPCVD Low Pressure Chemical Vapor Deposition
  • a metal catalyst such as nickel, copper, aluminum, iron is deposited on a wafer having a silicon oxide layer using a sputtering device and an electron beam evaporation device to form a metal catalyst layer, CH 4 , C 2 H 2 It is put in a reactor together with a gas containing carbon, such as, heated, so that carbon is absorbed in the metal catalyst layer, cooled to separate carbon from the metal catalyst layer and crystallized, and finally the metal By removing the catalyst layer, a graphene film can be formed.
  • a gas containing carbon such as, heated, so that carbon is absorbed in the metal catalyst layer, cooled to separate carbon from the metal catalyst layer and crystallized
  • the method for forming the graphene film is not limited to the chemical vapor deposition method, and various methods may be used to form the graphene film.
  • a graphene film can be formed by using an epitaxial synthesis method in which a material is heat-treated at a high temperature of 1,500 °C.
  • the pair of electrodes may be a source electrode and a drain electrode formed to be spaced apart from each other on the graphene film in order to apply a voltage to the graphene channel member.
  • the source electrode and the drain electrode may be electrically connected through the graphene film, may include a material having conductivity, and may be formed of, for example, a metal, a metal alloy, a conductive metal oxide, or a conductive metal nitride. .
  • the source electrode and the drain electrode are each independently Cu, Co, Bi, Be, Ag, Al, Au, Hf, Cr, In, Mn, Mo, Mg, Ni, Nb, Pb, Pd, Pt, Re, Rh, Sb, Ta, Te, Ti, W, V, Zr, Zn, and may include at least one selected from the group consisting of Zn and combinations thereof, but is not limited thereto, in terms of contact with graphene and ease of etching. , Au, or a Cr/Au alloy is preferred.
  • the pair of electrodes may be formed by a method known in the art, but for example, photolithography, thermal deposition, E-beam deposition, and plasma enhanced (PECVD). It may be formed by a deposition method such as Chemical Vapor Deposition), LPCVD (Low Pressure Chemical Vapor Deposition), PVD (Physical Vapor Deposition), sputtering, or ALD (Atomic Layer Deposition).
  • PECVD plasma enhanced
  • the graphene channel member may be one in which nanovesicles including TRPA1 are immobilized on the graphene film through a chemical bond, for example, poly-di-lysine.
  • Description of the graphene channel member, TRPA1, nanovesicle, poly-di-lysine, and graphene film is described in '1. It is the same as described in 'Graphene Channel Member'.
  • the graphene transistor including a graphene channel member in which TRPA1 is bonded to the graphene film in a form not included in the nanovesicle ie, TRPA1 is Compared to a graphene transistor immobilized on a graphene film or the like by a single physical or chemical bond), the sensitivity is higher and the detection limit is improved.
  • TRPA1 since nanovesicles have a cell-like structure, when TRPA1 contained in nanovesicles is used, TRPA1 can function identically or similarly to that of TRPA1 actually functioning in vivo, and the structural changes of TRPA1 It is possible to realize the difference in ion concentration inside and outside the nanovesicle by the inflow/outflow of ions that are generated accordingly. Therefore, when compared to a transistor or biosensor that uses only protein without using a nanovesicle, it is not possible to measure only the structural change of the protein itself or the resistance change according to it, but it is also possible to measure the movement of ions and the ion gradient inside and outside the nanovesicle.
  • the change of the electrical signal can be measured to be larger, and thus a higher sensitivity can be exhibited.
  • graphene since it has high charge mobility compared to materials having other semiconductor characteristics, it is possible to measure changes in electrical signals faster and with high sensitivity, which has the advantage that the detection limit can be improved accordingly.
  • Poly-D-lysine bound to the graphene film may form a linker layer in the form of a single layer, and the nanovesicles immobilized on the poly-D-lysine may also form an acceptor layer in the form of a single layer.
  • linker layer When the linker layer is formed as a single layer, graphene not only has excellent charge mobility, transparency and/or flexibility, but also has an effect of blocking noise signals due to the approach of external non-specific charges.
  • the linker layer may have a thickness of 0.1 to 2 nm.
  • the thickness of the linker layer is thinner than 0.1 nm, there is a problem in that resistance increases, and when it is thicker than 2 nm, there is a problem in that transparency is reduced.
  • Another aspect of the present invention provides a biosensor and a method for detecting a biocide using the same.
  • the biosensor includes the graphene transistor of the present invention.
  • the biosensor according to the present invention uses a semiconductor characteristic in which a current flowing in a graphene film between a source and a drain electrode is changed by an electric field effect.
  • the biosensor may be for detecting a biocide.
  • the description of the biocide that can be detected by the biosensor of the present invention is described in '1. It is the same as described in 'No graphene channel, for example, the biocide is PHMG (polyhexamethyleneguanidine), BNP (2-bromo-2-nitropropane-1,3-diol), OIT (2-Octyl-3 (2H)- from the group consisting of isothiazolone), CMIT (Chloromethylisothiazolinone), MIT (Methylisothiazolinone), CA (Citric acid), CBDZ (Carbendazim), SPO (Sodium 2-pyridinethiol 1-oxide), IPBC (iodopropynyl butylcarbamate) and DDAC (didecyldimethylammonium chloride) There may be one or more selected, and the biocide as described above may be included in household chemical products or processed foods.
  • the biosensor can detect even when the concentration of the biocide is 10 g/l or less, for example, 1 g/l or less, 100 mg/l or less, 10 mg/l or less, 1 mg/l or less, 100 ⁇ g/l or less A biocide of less than or equal to l, or less than or equal to 10 ⁇ g/l can be detected.
  • Such a biosensor is excellent in sensitivity, specificity, speed and/or portability by using the graphene transistor as described above, and in particular, due to the high charge carrier mobility and conductivity characteristics of graphene by using a graphene film as a channel layer. It has excellent sensitivity and real-time detection performance, thereby improving the detection limit of biocides that may be included in household chemicals or processed foods, thereby enabling detection with high sensitivity and reproducibility.
  • the above-mentioned graphene transistor is manufactured in the form of a SIM chip and can be applied to a miniaturized biosensor (portable electronic biocide sensor, etc.) It can be accurately identified in real time, and it can be used in various food industries and environmental evaluation industries.
  • the method for detecting a biocide from the sample includes: processing the sample with the biosensor of the present invention; and measuring an electrical signal of the biosensor.
  • the detection means confirming the presence of a target substance, and includes quantifying or semi-quantifying the concentration of a biocide that is a target substance.
  • the sample means any mixture or solution that contains or is suspected to contain a biocide, which is a target substance to be detected, and thus needs detection. It may be water, food, household products, by-products generated from household products, biological samples obtained from humans or animals, or processed products thereof that contain or are believed to contain biocides, such as household chemical products or processed foods.
  • the household chemical product may be, for example, an insecticide, a deodorant, and the like, but is not limited thereto.
  • the measurement of the electrical signal may be to measure the amount of change in the current, and specifically, by measuring the value obtained by dividing the value of the change in the current with time by the initial amount of current, the presence or absence of the biocide in the sample and / or the amount of the biocide Concentration and quantity can be detected.
  • the method of detecting the biocide from the sample may further include determining that the biocide is present in the sample when it is measured that the electrical signal of the biosensor changes.
  • the TRPA1 gene was transformed into HEK-293 cells, a type of mammalian cells, and the formation of nanovesicles was induced.
  • PCR is performed using the TRPA1 gene as a template to amplify it, and then rho-tag, an import sequence that induces the expression protein to move to the surface of the cell membrane. was fused with the PCR-amplified TRPA1 gene, and cloned into a mammalian expression vector, pCMV6-AC-GFP (CAT#: PS100010, OriGene).
  • the pCMV6-AC-GFP vector includes an ampicillin resistance gene, a CMV promoter, and a gene sequence encoding GFP, a green fluorescent protein.
  • 0.5 ⁇ g of the expression vector was diluted with 100 ⁇ l of Opti-MEM (Reduced Serum Media ) and mixed with 0.75 ⁇ l to 1.75 ⁇ l of a lipofectamine solution (Lipofectamine LTX TM , Invitrogen), followed by DNA-lipofectamine complex. was reacted at room temperature for 30 minutes to form Prior to introducing the expression vector into HEK-293 cells, the HEK-293 cells were humidified at 37 °C in DMEM medium (Dulbecco's Modified Eagle Medium, 4 mM L-glutamine, 10% FBS, 1% penicillin-streptomycin added).
  • DMEM medium Dulbecco's Modified Eagle Medium, 4 mM L-glutamine, 10% FBS, 1% penicillin-streptomycin added.
  • cytochalasin B cytochalasin B
  • B Sigma, USA
  • Cytochalasin B is a type of toxin (mycotoxin) capable of penetrating cell membranes, and can reduce the stability of cell membranes by interfering with the formation of contractile microfibers.
  • the expression vector was successfully introduced into HEK-293 cells and transformed, which means that the protein expressed therefrom is contained in the nanovesicle. . Since TRPA1 is encoded in the expression vector, it can be interpreted that TRPA1 fused with GFP is expressed in the nanovesicle through the above results.
  • a marker As a marker, a product from Bio-Rad was used, and as a control, a protein that was not solubilized by treatment with a surfactant was used. As a result of Western blotting, as shown in FIG. 2, a band was identified in the 151 kDa portion corresponding to the size of the TRPA1 protein (the combined size of 124 kDa TRPA1 and the 27 kDA GFP tag bound thereto), and TRPA1 was expressed and present. could confirm that
  • the nanovesicles prepared by the method of Preparation Example 1-1 were observed using a scanning electron microscope (Field Emission SEM, Magellan400). As a result, it was confirmed that the nanovesicles formed a spherical shape as shown in FIG. 3 . Combining the above measurement results, it can be seen that TRPA1 in a fused form with GFP is expressed and located on the surface film of the nanovesicle formed in the spherical shape of the present invention prepared by the method of Preparation Example 1-1. .
  • a copper foil was placed in the chamber, heated to 1,000 °C, and held at H 2 90 mTorr and 8 sccm for 30 min (20 min pre-annealing and 10 min stabilization), then CH 4 at 20 sccm 40 After applying a total pressure of 560 mTorr for minutes, it was cooled to 35 °C to 200 °C, and the furnace was cooled to room temperature to form a single graphene layer on the copper foil.
  • PMMA polymethyl methacrylate
  • the graphene layer washed as described above was transferred to a silicon wafer as a substrate, and then a PMMA solution was dropped on the graphene layer to remove the PMMA coating the graphene layer, thereby forming a graphene channel layer on the substrate. At this time, transparency was maintained at 97.8%.
  • a positive photoresist (AZ5214, Clariant Corp) was spin-coated on the graphene channel layer formed on the substrate, and then the graphene channel layer was patterned through UV exposure, baking and development processes.
  • a linker layer serving as a medium for fixing the graphene transistors and the nanovesicles was formed.
  • the linker poly-D-lysine (PDL) was used, the surface of the graphene layer was coated with a PDL solution of 0.1 mg/ml concentration, and the linker was reacted at 25° C. for 2 hours. layer was formed.
  • PDL poly-D-lysine
  • the nanoveg of the present invention A graphene transistor with a fixed claw was fabricated.
  • the electrical characteristics appearing in the graphene transistor in the form of a fixed nanovesicle containing TRPA1 prepared in Preparation Example 2 were measured using a source meter (Keithly 2412 sourcemteter) and a potentiometer (Wonatech 3000 potentiostat), Graphene transistor before fixing the nanovesicles (graphene transistors prepared up to Preparation Example 2-3, in which only a linker is coupled), graphene transistors before forming a linker layer (graphene transistors of Preparation Example 2-2) It is shown in FIG. 6 as compared with the measurement result of the electrical properties of .
  • the nano of the present invention In the graphene transistor with a fixed vesicle, the slope of the resistance increased. This is a result of resistance generated as nanovesicles containing TRPA1 are immobilized on the surface of graphene through a linker. It was confirmed that the immobilization of the nanovesicles was performed on the vesicles.
  • PHMG polyhexamethyleneguanidine
  • biocide a kind of biocide
  • the graphene transistor of the present invention has the effect of detecting PHMG according to the amount of PHMG, and a very high concentration of 10 ⁇ g/L It was confirmed that detection and detection were possible even at a small concentration.
  • OIT (2-Octyl-3(2H)-isothiazolone), CMIT (Chloromethylisothiazolinone) and PHMG as a biocide in a graphene transistor in which the nanovesicles containing TRPA1 prepared in Preparation Example 2 are fixed.
  • CMIT Chloromethylisothiazolinone
  • PHMG PHMG
  • the graphene transistor including the nanovesicles including TRPA1 of the present invention can detect and detect OIT and CMIT, but in particular, it has excellent detection effect on PHMG, and thus it can be confirmed that the selectivity is very large.
  • biocides As biocides, MIT, IPBC (iodopropynyl butylcarbamate), CA and DDAC (didecyldimethylammonium chloride) were used, and these were MIT + OIT, MIT + IPBC, MIT + CA, MIT + DDAC, DDAC + IPBC and DDAC + CA combinations, respectively.
  • MIT iodopropynyl butylcarbamate
  • CA dodopropynyl butylcarbamate
  • DDAC didecyldimethylammonium chloride
  • the transistor of the present invention can detect whether a component acting as a biocide is contained in a commercially available household chemical product. 5 ⁇ l of a total of 6 kinds of household chemical samples was put into the transistor of the present invention to measure electrical characteristics, and the measured sensitivity based on the value of the change in current with time is shown in FIG. 12 .
  • the household chemical products were measured by injecting a liquid sample collected by spraying the disinfectant and deodorant products in the form of spraying into the transistor of the present invention.
  • the transistor of the present invention can detect the biocide contained in household chemical products, and it can be confirmed that the transistor of the present invention can be used to quickly and conveniently detect the biocide present in the product.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Electrochemistry (AREA)
  • Mycology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Nanotechnology (AREA)
  • Thin Film Transistor (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

La présente invention concerne un élément de canal en graphène comprenant un film de graphène et une nanovésicule (contenant le TRPA1) immobilisée dans le film de graphène ; un transistor en graphène comprenant un substrat, l'élément de canal en graphène et une paire d'électrodes ; et un biocapteur comprenant le transistor en graphène. De plus, la présente invention concerne un procédé de détection d'un biocide présent dans un échantillon, le procédé comprenant les étapes consistant à : traiter l'échantillon dans le biocapteur ; et mesurer un signal électrique dans le biocapteur.
PCT/KR2021/003555 2020-03-23 2021-03-23 Élément de canal en graphène comprenant une nanovésicule contenant le trpa1, et biocapteur WO2021194207A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2020-0035224 2020-03-23
KR1020200035224A KR102504692B1 (ko) 2020-03-23 2020-03-23 Trpa1을 포함하는 나노베지클을 포함하는 그래핀 채널 부재, 및 바이오 센서

Publications (1)

Publication Number Publication Date
WO2021194207A1 true WO2021194207A1 (fr) 2021-09-30

Family

ID=77890510

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/003555 WO2021194207A1 (fr) 2020-03-23 2021-03-23 Élément de canal en graphène comprenant une nanovésicule contenant le trpa1, et biocapteur

Country Status (2)

Country Link
KR (1) KR102504692B1 (fr)
WO (1) WO2021194207A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150031747A (ko) * 2013-09-16 2015-03-25 서울대학교산학협력단 인간 도파민 수용체를 포함하는 나노베지클, 및 이를 포함하는 도파민 수용체 및 전계 효과 트랜지스터 기반 도파민 센서
KR20170051058A (ko) * 2015-11-02 2017-05-11 국민대학교산학협력단 미각 수용체를 이용한 살충제 또는 기피제의 스크리닝 방법
WO2018116186A1 (fr) * 2016-12-21 2018-06-28 The New Zealand Institute For Plant And Food Research Dispositif de détection et procédés

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100839622B1 (ko) * 2006-04-28 2008-06-19 재단법인서울대학교산학협력재단 Ｔｒｐ 채널의 블로커를 포함하는 치통치료제 및 이의스크리닝방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150031747A (ko) * 2013-09-16 2015-03-25 서울대학교산학협력단 인간 도파민 수용체를 포함하는 나노베지클, 및 이를 포함하는 도파민 수용체 및 전계 효과 트랜지스터 기반 도파민 센서
KR20170051058A (ko) * 2015-11-02 2017-05-11 국민대학교산학협력단 미각 수용체를 이용한 살충제 또는 기피제의 스크리닝 방법
WO2018116186A1 (fr) * 2016-12-21 2018-06-28 The New Zealand Institute For Plant And Food Research Dispositif de détection et procédés

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AHN SAE RYUN, AN JI HYUN, SONG HYUN SEOK, PARK JIN WOOK, LEE SANG HUN, KIM JAE HYUN, JANG JYONGSIK, PARK TAI HYUN: "Duplex Bioelectronic Tongue for Sensing Umami and Sweet Tastes Based on Human Taste Receptor Nanovesicles", ACS NANO, AMERICAN CHEMICAL SOCIETY, US, vol. 10, no. 8, 23 August 2016 (2016-08-23), US, pages 7287 - 7296, XP055852817, ISSN: 1936-0851, DOI: 10.1021/acsnano.6b02547 *
Y. WANG, ET AL.: "Charging the Quantum Capacitance of Graphene with a Single Biological Ion Channel", ACS NANO, AMERICAN CHEMICAL SOCIETY, US, vol. 8, no. 5, 27 May 2014 (2014-05-27), US, pages 4228 - 4238, XP055512623, ISSN: 1936-0851, DOI: 10.1021/nn501376z *

Also Published As

Publication number Publication date
KR102504692B1 (ko) 2023-03-02
KR20210118671A (ko) 2021-10-01

Similar Documents

Publication Publication Date Title
US9029168B2 (en) Use and making of biosensors utilizing antimicrobial peptides for highly sensitive biological monitoring
Han et al. The role of microsporidian polar tube protein 4 (PTP4) in host cell infection
McIlroy et al. Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila melanogaster CNS
CN102369210A (zh) 抗菌肽
Guo et al. A porin-like protein from oral secretions of Spodoptera littoralis larvae induces defense-related early events in plant leaves
JP2020041947A (ja) ケミカルセンサ及び標的物質検出方法
WO2016036145A1 (fr) Capteur de détection de norovirus et procédé de détection électrochimique utilisant celui-ci
Moitra et al. A novel bio-engineering approach to generate an eminent surface-functionalized template for selective detection of female sex pheromone of Helicoverpa armigera
WO2021194207A1 (fr) Élément de canal en graphène comprenant une nanovésicule contenant le trpa1, et biocapteur
Mikušová et al. Amperometric immunosensor for rapid detection of honeybee pathogen Melissococcus Plutonius
Ishikawa et al. Rapid and label-free cell detection by metal-cluster-decorated carbon nanotube biosensors
Bingham et al. Analysis of a cone snail's killer cocktail–The milked venom of Conus geographus
WO2013051790A2 (fr) Biocapteur utilisant un transistor à effet de champ
Vasilopoulos et al. Graphene-wrapped copper nanoparticles: an antimicrobial and biocompatible nanomaterial with valuable properties for medical uses
Hosseini et al. Fundamentals and history of ELISA: the evolution of the immunoassays until invention of ELISA
Kazuma et al. Peptidomic analysis of the venom of the solitary bee Xylocopa appendiculata circumvolans
Liu et al. Increased talin–vinculin spatial proximities in livers in response to spotted fever group rickettsial and Ebola virus infections
Chiu et al. Site-selective biofunctionalization of aluminum nitride surfaces using patterned organosilane self-assembled monolayers
Dias et al. Evidence that a laminin-like insect protein mediates early events in the interaction of a Phytoparasite with its vector's salivary gland
EP0784791B1 (fr) Biodetecteur comportant un biomateriau fixe de maniere covalente sur une surface emettant un signal de reaction
Wang et al. Recombinant Bacillus thuringiensis strain shows high insecticidal activity against Plutella xylostella and Leptinotarsa decemlineata without affecting nontarget species in the field
Silva-Filha et al. Culex quinquefasciatus field populations subjected to treatment with Bacillus sphaericus did not display high resistance levels
Kumar et al. Microbial biosensors for methyl parathion: From single to multiple samples analysis
Fisher et al. Intracellular Ca2+ channel immunoreactivity in neuroendocrine axon terminals
IT202100000533A1 (it) Biosensore a transistor a effetto di campo (fet) per la rilevazione di particelle virali

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21775224

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21775224

Country of ref document: EP

Kind code of ref document: A1